CLS B — Clinical Laserthermia Systems AB Share News
0.000.00%
Last trade - 00:00- SEK109.86m
- SEK93.54m
- SEK17.49m
ClearPoint Neuro up on FDA clearance for partner's laser therapy system
Brief: Clearpoint Neuro Announces FDA Clearance For Clearpoint Prism Neuro Laser Therapy System
Brief: Clinical Laserthermia Systems: Outcome Of Rights Issue Of Units
Brief: CLS Shareholder Khattar Subscribes For B-Shares In Rights Issue
Brief: Clinical Laserthermia Systems Appoints New CFO
Brief: Clinical Laserthermia Systems Q2 Loss After Financial Items Narrows To SEK 17 Mln
Brief: Clinical Laserthermia Systems Says Board Resolves On Rights Issue Of Units For Initial Amount Of About 69.3 Msek
Brief: Clinical Laserthermia Systems Q1 Pre-Tax Loss Widens To SEK 13.8 Mln
Brief: CLS Appoints Dan J. Mogren As Permanent CEO
Brief: Clinical Laserthermia Systems Enters Agreement With Quadia Diagnostic Imaging Center
Brief: Clinical Laserthermia Systems Acting CEO Returns To Work
Brief: CLS Granted Patent In China For Product And Method Of Controlling Treatment With imILT Protocol
Brief: Clinical Laserthermia Systems Q4 Loss After Financial Items Widens To Sek 19.6 Mln
Brief: CLS's Acting CEO Dan J. Mogren To Go On Planned Sick Leave
Brief: CLS And Skåne University Hospital Enter Clinical Trial Agreement
Brief: CLS Files Application For Approval Of Tranberg To U.S. FDA
Brief: Clinical Laserthermia Systems Q3 EBIT Loss Widens To SEK 11.9 Mln
Brief: CLS Q2 Pretax Loss Widens To SEK 23.1 Million
Brief: CLS, Toronto General Hospital Resume Clinical Trial For Prostate Cancer As Co Receives Approval For Updated Sterilization Process By Health Canada